SEMBER MICHAEL T. - 01 Jan 2023 Form 3 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Director
Signature
/s/ Michael Sember
Issuer symbol
QNRX
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
3
Filing time
07 Mar 2023, 18:15:32 UTC
Next filing
30 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QNRX Share Option (right to buy) 01 Jan 2023 Ordinary Shares 64,285,600 $0.003500 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three equal annual installments beginning on April 12, 2023.
F2 The number of securities underlying the option and the exercise price are listed in terms of ordinary shares, with five thousand (5,000) ordinary shares of the Issuer represented by one (1) American Depositary Share ("ADS"), which evidences the grant of an option to buy 12,857.12 ADSs at the exercise price of $17.50 per ADS.